LXRX Earnings

Quarterly EPS
$-0.18
Q3 2024
$-0.09
Q4 2024
$-0.07
Q1 2025
$0.01
Q2 2025
$-0.04
Q3 2025
$-0.04
Q4 2025
$0.00
Q1 2026
$-0.07
Q2 2026
Latest Revenue692.0K
Latest Net Income-31775000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.07692.0K-31775000-97.6%-800.0%
Q1 2026$0.0021.1M-1043000+1,572.1%+100.0%
Q4 2025-$0.045.3M-15530000-79.8%+55.6%
Q3 2025-$0.0414.2M-12769000+710.4%+77.8%
Q2 2025$0.0128.9M3.3M+1,652.6%+105.9%
Q1 2025-$0.071.3M-25295000+11.7%+65.0%
Q4 2024-$0.0926.5M-33766000+3,839.6%+55.0%
Q3 2024-$0.181.8M-64811000+1,082.4%+14.3%
Q2 2024-$0.171.6M-53429000
Q1 2024-$0.201.1M-48397000
Q4 2023-$0.20672.0K-49756000
Q3 2023-$0.21148.0K-50525000
Lexicon Pharmaceuticals (LXRX) — Earnings